{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:09:25Z","timestamp":1790248165656,"version":"4.1.0"},"reference-count":92,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Center, Poland","doi-asserted-by":"publisher","award":["OPUS 19 (2020\/37\/B\/NZ5\/03249)"],"award-info":[{"award-number":["OPUS 19 (2020\/37\/B\/NZ5\/03249)"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"award":["OPUS 19 (2020\/37\/B\/NZ5\/03249)"],"award-info":[{"award-number":["OPUS 19 (2020\/37\/B\/NZ5\/03249)"]}],"id":[{"id":"https:\/\/ror.org\/03ha2q922","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Glioblastoma remains one of the most aggressive primary brain tumors, characterized by rapid progression, therapeutic resistance, and poor prognosis. Dexamethasone is routinely administered to patients with glioblastoma to reduce peritumoral edema and improve neurological symptoms. However, its broader molecular effects on tumor-cell biology and treatment response remain incompletely understood. This study examined the effects of dexamethasone alone and in combination with temozolomide, valproic acid, or metformin on glioblastoma cell viability, real-time proliferation, senescence-associated \u03b2-galactosidase activity, cell-cycle distribution, global DNA methylation, and oxidative DNA damage. Dexamethasone induced concentration- and time-dependent changes in global DNA methylation in glioma cells. In T98G cells, shorter exposure increased 5-methylcytosine, whereas longer incubation or selected combined treatment conditions reduced methylation, suggesting dynamic epigenetic remodeling. Low dexamethasone concentrations were associated with increased 5-methylcytosine content, also in temozolomide-containing conditions. In contrast, higher dexamethasone concentrations reduced global methylation. That effect was cell-line dependent. In SW1783 cells, high-dose dexamethasone caused a reduction in 5-methylcytosine amount as well as an increase in 8-oxo-2\u2032-deoxyguanosine level. Dexamethasone also reduced real-time T98G cell proliferation after prolonged exposure, while temozolomide was the main compound associated with cell-cycle changes in T98G cells. Metformin displayed comparatively limited cytotoxicity under the tested conditions. Beyond dexamethasone\u2019s well-established anti-edematous and anti-inflammatory role, it may also modify glioma redox and epigenetic states and influence cellular responses to temozolomide, valproic acid, and metformin. When considering these findings it is necessary to take into account a number of limitations. The upper limits of the DEX, TMZ, and MF concentration ranges were one to three orders of magnitude higher than the brain or CSF exposure levels that have been reported, and the experiments were carried out at standard culture oxygen concentrations (about 18\u201321% O2), which are much higher than the oxygen levels found in brain tissue (about 2\u20136% O2). Furthermore, the conclusions drawn from the T98G experiments only apply to this cell line and cannot be applied to glioblastoma without first being verified in other models.<\/jats:p>","DOI":"10.3390\/cells15191745","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:16:28Z","timestamp":1790244988000},"page":"1745","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dexamethasone Modulates Global DNA Methylation and Oxidative DNA Damage in Glioblastoma Cell Lines"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7179-1474","authenticated-orcid":false,"given":"Anna-Maria","family":"Barciszewska","sequence":"first","affiliation":[{"name":"Intraoperative Imaging Unit, Department of Neurosurgery, Institute of Nervous System Diseases, Poznan University of Medical Sciences, Przybyszewskiego 49, 60-355 Pozna\u0144, Poland"},{"name":"Department of Neurosurgery, University Clinical Hospital, Przybyszewskiego 49, 60-355 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-4986","authenticated-orcid":false,"given":"Agnieszka","family":"Belter","sequence":"additional","affiliation":[{"name":"Institute of Bioorganic Chemistry of the Polish Academy of Sciences, Noskowskiego 12, 61-704 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"}]},{"given":"Jakub F.","family":"Barciszewski","sequence":"additional","affiliation":[{"name":"Institute of Bioorganic Chemistry of the Polish Academy of Sciences, Noskowskiego 12, 61-704 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"given":"Patrick M.","family":"Perrigue","sequence":"additional","affiliation":[{"name":"NanoBioMedical Center, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, 61-614 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Kaja","family":"Jaskot","sequence":"additional","affiliation":[{"name":"NanoBioMedical Center, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, 61-614 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Ma\u0142gorzata","family":"Giel-Pietraszuk","sequence":"additional","affiliation":[{"name":"Institute of Bioorganic Chemistry of the Polish Academy of Sciences, Noskowskiego 12, 61-704 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Miros\u0142awa Z.","family":"Naskr\u0119t-Barciszewska","sequence":"additional","affiliation":[{"name":"Institute of Bioorganic Chemistry of the Polish Academy of Sciences, Noskowskiego 12, 61-704 Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.3748\/wjg.v10.i23.3441","article-title":"Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis","volume":"10","author":"Xu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"r54","DOI":"10.1186\/gb-2014-15-4-r54","article-title":"DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns","volume":"15","author":"Lokk","year":"2014","journal-title":"Genome Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"a019505","DOI":"10.1101\/cshperspect.a019505","article-title":"Epigenetic determinants of cancer","volume":"8","author":"Baylin","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1073\/pnas.0510310103","article-title":"A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters","volume":"103","author":"Saxonov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1146\/annurev-biochem-060713-035513","article-title":"Mechanism and function of oxidative reversal of DNA and RNA methylation","volume":"83","author":"Shen","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/gb-2013-14-9-r102","article-title":"Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape","volume":"14","author":"Day","year":"2013","journal-title":"Genome Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.cell.2011.08.042","article-title":"DNA demethylation dynamics","volume":"146","author":"Bhutani","year":"2011","journal-title":"Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e10033","DOI":"10.1002\/ggn2.10033","article-title":"Active DNA demethylation. The epigenetic gatekeeper of development, immunity, and cancer","volume":"2","author":"Prasad","year":"2021","journal-title":"Adv. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1389450116666150113121054","article-title":"ROS-mediated DNA methylation pattern alterations in carcinogenesis","volume":"16","author":"Wu","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","article-title":"Free radicals, metals and antioxidants in oxidative stress-induced cancer","volume":"160","author":"Valko","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.tips.2017.04.005","article-title":"Targeting Free Radicals in Oxidative Stress-Related Human Diseases","volume":"38","author":"Poprac","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: Initiators, amplifiers or an Achilles\u2019 heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/epi.09.33","article-title":"DNA hypomethylation in cancer cells","volume":"1","author":"Ehrlich","year":"2009","journal-title":"Epigenomics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.dnarep.2017.06.009","article-title":"8-Oxo-7, 8-dihydroguanine, friend and foe: Epigenetic-like regulator versus initiator of mutagenesis","volume":"56","author":"Fleming","year":"2017","journal-title":"DNA Repair."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrg3142","article-title":"Epigenetics and the environment: Emerging patterns and implications","volume":"13","author":"Feil","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Barciszewska, A.M., Belter, A., Barciszewski, J.F., Gawro\u0144ska, I., Giel-Pietraszuk, M., and Naskr\u0119t-Barciszewska, M.Z. (2024). Mechanistic Insights on metformin and arginine implementation as repurposed drugs in glioblastoma treatment. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179460"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Barciszewska, A.M., Gurda, D., G\u0142odowicz, P., Nowak, S., and Naskr\u0119t-Barciszewska, M.Z. (2015). A new epigenetic mechanism of temozolomide action in glioma cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136669"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Barciszewska, A.M., Giel-Pietraszuk, M., Perrigue, P.M., and Naskr\u0119t-Barciszewska, M.Z. (2019). Total DNA methylation changes reflect random oxidative DNA damage in gliomas. Cells, 8.","DOI":"10.3390\/cells8091065"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"King, J.L., and Benhabbour, S.R. (2021). Glioblastoma Multiforme-A Look at the Past and a Glance at the Future. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13071053"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wang, Y., Chen, W., Shi, Y., Yan, C., Kong, Z., Wang, Y., and Ma, W. (2021). Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.719623"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Karve, A.S., Desai, J.M., Gadgil, S.N., Dave, N., Wise-Drape, T.M., Gudelsk, G.A., Phoenix, T.N., DasGupta, B., Yogendran, L., and Sengupta, S. (2024). A review of approaches to potentiate the activity of temozolomide against glioblastoma to overcome resistance. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063217"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12672-025-02567-3","article-title":"Glioblastoma multiforme: An updated overview of temozolomide resistance mechanisms and strategies to overcome resistance","volume":"16","author":"Pu","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"103540","DOI":"10.1016\/j.critrevonc.2021.103540","article-title":"The current landscape of systemic therapy for recurrent glioblastoma: A systematic review of randomized-controlled trials","volume":"169","author":"Fazzari","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/brain\/aww046","article-title":"Corticosteroids compromise survival in glioblastoma","volume":"139","author":"Pitter","year":"2016","journal-title":"Brain"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhou, L., Shen, Y., Huang, T., Sun, Y., Alolga, R.N., and Zhang, G. (2021). The Prognostic Effect of Dexamethasone on Patients With Glioblastoma: A Systematic Review and Meta-Analysis. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.727707"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Krauze, A.V., Zhao, Y., Li, M.C., Shih, J., Jiang, W., Tasci, E., Zgela, T.C., Sproull, M., Mackey, M., and Shankavaram, U. (2023). Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation. Biomolecules, 13.","DOI":"10.3390\/biom13101499"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"viii299","DOI":"10.1093\/neuonc\/noae165.1189","article-title":"TMIC-11. The effectiveness of valproic acid in combination with temozolomide for treatment of high-grade gliomas: A systematic review and meta-analysis","volume":"26","author":"Sharma","year":"2024","journal-title":"Neuro Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"36804","DOI":"10.1038\/s41598-025-20749-5","article-title":"Histone deacetylase inhibitors sensitize glioblastoma models to temozolomide and reprogram immunosuppressive myeloid cells","volume":"15","author":"Tehrani","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11010-022-04502-4","article-title":"Mechanisms of cancer cell killing by metformin: A review on different cell death pathways","volume":"478","author":"Wu","year":"2023","journal-title":"Mol. Cell Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Sharma, S., Zhang, Y., Akter, K.A., Nozohouri, S., Archie, S.R., Patel, D., Villalba, H., and Abbruscato, T. (2023). Permeability of Metformin across an In Vitro Blood-Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs). Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15051357"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sesen, J., Dahan, P., Scotland, S.J., Saland, E., Dang, V.T., Lemari\u00e9, A., Tyler, B.M., Brem, H., Toulas, C., and Moyal, E.C.-J. (2015). Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123721"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Hajimohammadebrahim-Ketabforoush, M., Zali, A., Shahmohammadi, M., and Hamidieh, A.A. (2024). Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1455492"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/0271678X19859847","article-title":"Controversial roles for dexamethasone in glioblastoma\u2014Opportunities for novel vascular targeting therapies","volume":"39","author":"Dubinski","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11060-023-04549-3","article-title":"Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: A meta-analysis","volume":"166","author":"Arora","year":"2024","journal-title":"J. Neurooncol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Scheffler, P., Fung, C., Momjian, S., Koessinger, D., H\u00e4ni, L., Neidert, N., Straehle, J., Volz, F., Schnell, O., and Beck, J. (2024). Dexamethasone in patients with glioblastoma: A systematic review and meta-analysis. Cancers, 16.","DOI":"10.3390\/cancers16071393"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"105968","DOI":"10.1016\/j.bas.2026.105968","article-title":"The role of dexamethasone during treatment phases in glioblastoma: Insights from a retrospective observational study","volume":"6","author":"Scheer","year":"2026","journal-title":"Brain Spine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/bjc.2015.238","article-title":"Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma","volume":"113","author":"Wong","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/1078-0432.CCR-20-2291","article-title":"Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma","volume":"27","author":"Iorgulescu","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e003368","DOI":"10.1136\/jitc-2021-003368","article-title":"Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models","volume":"10","author":"Koch","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ohmura, K., Tomita, H., and Hara, A. (2023). Peritumoral Edema in Gliomas: A Review of Mechanisms and Management. Biomedicines, 11.","DOI":"10.3390\/biomedicines11102731"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrn2175","article-title":"Angiogenesis in brain tumours","volume":"8","author":"Jain","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The Microenvironmental Landscape of Brain Tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood-brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11060-009-0057-4","article-title":"The role of steroids in the management of brain metastases: A systematic review and evidence-based clinical practice guideline","volume":"96","author":"Ryken","year":"2010","journal-title":"J. Neurooncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1549-8719.2000.tb00117.x","article-title":"The microcirculation and inflammation: Site of action for glucocorticoids","volume":"7","author":"Perretti","year":"2000","journal-title":"Microcirculation"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1158\/1078-0432.CCR-09-1349","article-title":"The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: Potential implications for the current approach to chemoradiation","volume":"15","author":"Portnow","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"20018","DOI":"10.1038\/s41598-019-56574-w","article-title":"Comorbid Medical Conditions as Predictors of Overall Survival in Glioblastoma Patients","volume":"9","author":"Carr","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"iii21","DOI":"10.1093\/neuonc\/noad147.090","article-title":"An audit of steroid-induced diabetes in primary brain tumour patients","volume":"25","author":"Bog","year":"2023","journal-title":"Neuro-Oncology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"142","DOI":"10.7150\/ijms.77206","article-title":"A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes","volume":"20","author":"Damanhouri","year":"2023","journal-title":"Int. J. Med. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Mazurek, M., Litak, J., Kamieniak, P., Kulesza, B., Jonak, K., Baj, J., and Grochowski, C. (2020). Metformin as Potential Therapy for High-Grade Glioma. Cancers, 12.","DOI":"10.3390\/cancers12010210"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Valtorta, S., Lo Dico, A., Raccagni, I., Martelli, C., Pieri, V., Rainone, P., Todde, S., Zinnhardt, B., De Bernardi, E., and Coliva, A. (2021). Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.664149"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ma, X., Sun, C., Ding, X., Zhang, Y., Deng, T., Wang, Y., Yang, H., Ding, R., Li, H., and Wang, D. (2025). Advances in the treatment of glioma-related signaling pathways and mechanisms by metformin. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1482050"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Cavaliere, F., Pellegrino, M., Cormace, A., Spadafora, S., Fava, M., Yang, S.H., Lee, J.F., Nocito, M.C., Sirianni, R., and Casaburi, I. (2026). Metformin Suppresses Glioblastoma Tumor Growth and Progression Through the AMPK\/FoxO3a\/Survivin Axis. Cells, 15.","DOI":"10.3390\/cells15030310"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.3892\/etm.2014.1597","article-title":"Effect of Metformin on the Human T98G Glioblastoma Multiforme Cell Line","volume":"7","author":"Ucbek","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gonzales-Portillo, D., Vashi, B., Williams, K.B., and Cervantes, J. (2026). Metformin Renders Survival Advantage to Patients with Glioblastoma Multiforme. Neurol. Int., 18.","DOI":"10.3390\/neurolint18030040"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.abj6987","article-title":"The complete sequence of a human genome","volume":"376","author":"Nurk","year":"2022","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10517-024-06294-7","article-title":"Mesenchymal Properties of Glioma Cell Lines","volume":"178","author":"Kholodenko","year":"2024","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1158\/2159-8290.CD-16-0177","article-title":"Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation","volume":"6","author":"Khattar","year":"2016","journal-title":"Cancer Discov."},{"key":"ref_68","first-page":"2050","article-title":"Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-\u03baB-dependent pathway","volume":"27","author":"Huang","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13014-023-02241-4","article-title":"Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data","volume":"18","author":"Piehlmaier","year":"2023","journal-title":"Radiat. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Fan, Z., Sehm, T., Rauh, M., Buchfelder, M., Eyupoglu, I.Y., and Savaskan, N.E. (2014). Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0093264"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1177\/1087057105279635","article-title":"Dynamic monitoring of cell adhesion and spreading on microelectronic sensor arrays","volume":"10","author":"Atienza","year":"2005","journal-title":"J. Biomol. Screen."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-61779-108-6_6","article-title":"The xCELLigence system for real-time and label-free monitoring of cell viability","volume":"740","author":"Ke","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature25167","article-title":"Senescence-associated reprogramming promotes cancer stemness","volume":"553","author":"Milanovic","year":"2018","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"Unmasking senescence: Context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1474-9726.2006.00199.x","article-title":"Senescence-associated \u03b2-galactosidase is lysosomal \u03b2-galactosidase","volume":"5","author":"Lee","year":"2006","journal-title":"Aging Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nrd.2017.116","article-title":"Senescent cells: An emerging target for diseases of ageing","volume":"16","author":"Childs","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4419-6199-0_9","article-title":"Analysis of cellular DNA content by flow and laser scanning cytometry","volume":"676","author":"Darzynkiewicz","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.molmed.2006.07.007","article-title":"DNA damage-induced cell death by apoptosis","volume":"12","author":"Roos","year":"2006","journal-title":"Trends Mol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nn.3275","article-title":"Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions","volume":"16","author":"Klengel","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/npp.2015.235","article-title":"Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications","volume":"41","author":"Zannas","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13148-019-0682-5","article-title":"Identification of dynamic glucocorticoid-induced methylation changes at the FKBP5 locus","volume":"11","author":"Wiechmann","year":"2019","journal-title":"Clin. Epigenet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1210\/clinem\/dgae151","article-title":"Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome","volume":"109","author":"Paes","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_85","first-page":"120","article-title":"8-hydroxy-2\u2032-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"09636897231177356","DOI":"10.1177\/09636897231177356","article-title":"Dexamethasone Induces Senescence-Associated Changes in Trabecular Meshwork Cells by Increasing ROS Levels Via the TGF\u03b2\/Smad3-NOX4 Axis","volume":"32","author":"Li","year":"2023","journal-title":"Cell Transplant."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Barciszewska, A.M., Nowak, S., and Naskr\u0119t-Barciszewska, M.Z. (2014). The degree of global DNA hypomethylation in peripheral blood correlates with that in matched tumor tissue in several neoplasia. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092599"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Belter, A., Barciszewski, J., and Barciszewska, A.-M. (2020). Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0229534"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1179\/016164102101200203","article-title":"The tissue level of dexamethasone in human brain tumors is about 1000 times lower than the cytotoxic concentration in cell culture","volume":"24","author":"Nestler","year":"2002","journal-title":"Neurol. Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Barciszewska, A.-M., Belter, A., Gawro\u0144ska, I., Giel-Pietraszuk, M., and Naskr\u0119t-Barciszewska, M.Z. (2022). Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1033035"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Alva, R., Gardner, G.L., Liang, P., and Stuart, J.A. (2022). Supraphysiological Oxygen Levels in Mammalian Cell Culture: Current State and Future Perspectives. Cells, 11.","DOI":"10.3390\/cells11193123"},{"key":"ref_92","first-page":"375","article-title":"Peri-tumoural hypoxia in human brain: Peroperative measurement of the tissue oxygen tension around malignant brain tumours","volume":"60","author":"Cruickshank","year":"1994","journal-title":"Acta Neurochir. Suppl."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/19\/1745\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T10:28:00Z","timestamp":1790245680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/19\/1745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":92,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cells15191745"],"URL":"https:\/\/doi.org\/10.3390\/cells15191745","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}